Maximizing Value In Outsourcing Services
- Topics:
- Outsourced Services
- Tags:
- Biotechnology,
- Outsourcing & Subcontracting,
- Outsourcing,
- Outsource,
- Managed Hosting,
- It Operations,
- Genetic Engineering & Biotechnology News,
- Genetic Engineering,
- Business Operations,
- Pharmaceutical Company
FREE Registration is required
Overview: The pharmaceutical industry is, without a doubt, feeling the crunch of skyrocketing costs, lackluster pipelines, and drug safety issues. Clinical professionals need to do more with less, while still maintaining the highest levels of quality. Many companies are choosing Contract Research Organizations (CROs) as a cost-effective strategy to outsource services ranging from drug development to managing and monitoring clinical trials. Biotech and pharmaceutical companies often choose CRO suppliers and the required central labs independent of each other. The ultimate goal of outsourcing is to achieve three project drivers: efficient use of time, high-quality products, and mutual value-based cost (i.e., the price charged is equivalent to the value of the service provided).
(Is this item miscategorized? Does it need more tags? Let us know.)
Format: HTML | Date: Mar 2009
